Polycomb and Trithorax factors in transcriptional and epigenetic regulation

Epigenetic Gene Expression and Regulation

Volumn , Issue , 2015, Pages 63-94

  Lau, Priscilla Nga Ieng ^a   So, Chi Wai Eric ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chromatin; Epigenetics; Gene expression; Histone methylation; Polycomb; Trithorax

Indexed keywords

EID: 85017343879     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-799958-6.00004-4     Document Type: Chapter

References (153)

1. Felsenfeld G., Groudine M. Controlling the double helix. Nature 2003, 421(6921):448-453.
2. Luger K., Mader A.W., Richmond R.K., Sargent D.F., Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997, 389(6648):251-260.
3. Bannister A.J., Kouzarides T. Regulation of chromatin by histone modifications. Cell Res 2011, 21(3):381-395.
4. Gardner K.E., Allis C.D., Strahl B.D. Operating on chromatin, a colorful language where context matters. J Mol Biol 2011, 409(1):36-46.
5. Musselman C.A., Lalonde M.E., Cote J., Kutateladze T.G. Perceiving the epigenetic landscape through histone readers. Nat Struct Mol Biol 2012, 19(12):1218-1227.
6. Plass C., Pfister S.M., Lindroth A.M., Bogatyrova O., Claus R., Lichter P. Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat Rev Genet 2013, 14(11):765-780.
7. Portela A., Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010, 28(10):1057-1068.
8. Mills A.A. Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins. Nat Rev Cancer 2010, 10(10):669-682.
9. Schuettengruber B., Martinez A.M., Iovino N., Cavalli G. Trithorax group proteins: switching genes on and keeping them active. Nat Rev Mol Cell Biol 2011, 12(12):799-814.
10. Laugesen A., Helin K. Chromatin repressive complexes in stem cells, development, and cancer. Cell Stem Cell 2014, 14(6):735-751.
11. Kennison J.A. The Polycomb and trithorax group proteins of Drosophila: trans-regulators of homeotic gene function. Annu Rev Genet 1995, 29:289-303.
12. Lewis E.B. A gene complex controlling segmentation in Drosophila. Nature 1978, 276(5688):565-570.
13. Ingham P.W., Whittle R. Trithorax: a new homoeotic mutation of Drosophila melanogaster causing transformations of abdominal and thoracic imaginal segments. Mol Gen Genet MGG 1980, 179:607-614.
14. van der Lugt N.M., Domen J., Linders K., van Roon M., Robanus-Maandag E., te Riele H., et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev 1994, 8(7):757-769.
15. Yu B.D., Hess J.L., Horning S.E., Brown G.A., Korsmeyer S.J. Altered Hox expression and segmental identity in Mll-mutant mice. Nature 1995, 378(6556):505-508.
16. del Mar Lorente M., Marcos-Gutierrez C., Perez C., Schoorlemmer J., Ramirez A., Magin T., et al. Loss- and gain-of-function mutations show a polycomb group function for Ring1A in mice. Development 2000, 127(23):5093-5100.
17. Shilatifard A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu Rev Biochem 2012, 81:65-95.
18. Bracken A.P., Dietrich N., Pasini D., Hansen K.H., Helin K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 2006, 20(9):1123-1136.
19. Lee T.I., Jenner R.G., Boyer L.A., Guenther M.G., Levine S.S., Kumar R.M., et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006, 125(2):301-313.
20. O'Meara M.M., Simon J.A. Inner workings and regulatory inputs that control Polycomb repressive complex 2. Chromosoma 2012, 121(3):221-234.
21. Margueron R., Li G., Sarma K., Blais A., Zavadil J., Woodcock C.L., et al. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol Cell 2008, 32(4):503-518.
22. Son J., Shen S.S., Margueron R., Reinberg D. Nucleosome-binding activities within JARID2 and EZH1 regulate the function of PRC2 on chromatin. Genes Dev 2013, 27(24):2663-2677.
23. Shen X., Liu Y., Hsu Y.J., Fujiwara Y., Kim J., Mao X., et al. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol Cell 2008, 32(4):491-502.
24. Ezhkova E., Lien W.H., Stokes N., Pasolli H.A., Silva J.M., Fuchs E. EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair. Genes Dev 2011, 25(5):485-498.
25. Margueron R., Justin N., Ohno K., Sharpe M.L., Son J., Drury W.J., et al. Role of the polycomb protein EED in the propagation of repressive histone marks. Nature 2009, 461(7265):762-767.
26. Yuan W., Wu T., Fu H., Dai C., Wu H., Liu N., et al. Dense chromatin activates Polycomb repressive complex 2 to regulate H3 lysine 27 methylation. Science 2012, 337(6097):971-975.
27. Cao R., Zhang Y. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol Cell 2004, 15(1):57-67.
28. Herz H.M., Shilatifard A. The JARID2-PRC2 duality. Genes Dev 2010, 24(9):857-861.
29. Nekrasov M., Klymenko T., Fraterman S., Papp B., Oktaba K., Kocher T., et al. Pcl-PRC2 is needed to generate high levels of H3-K27 trimethylation at Polycomb target genes. EMBO J 2007, 26(18):4078-4088.
30. Sarma K., Margueron R., Ivanov A., Pirrotta V., Reinberg D. Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo. Mol Cell Biol 2008, 28(8):2718-2731.
31. Schwartz Y.B., Pirrotta V. A new world of Polycombs: unexpected partnerships and emerging functions. Nat Rev Genet 2013, 14(12):853-864.
32. Di Croce L., Helin K. Transcriptional regulation by Polycomb group proteins. Nat Struct Mol Biol 2013, 20(10):1147-1155.
33. Ku M., Koche R.P., Rheinbay E., Mendenhall E.M., Endoh M., Mikkelsen T.S., et al. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet 2008, 4(10):e1000242.
34. Leeb M., Pasini D., Novatchkova M., Jaritz M., Helin K., Wutz A. Polycomb complexes act redundantly to repress genomic repeats and genes. Genes Dev 2010, 24(3):265-276.
35. Schoeftner S., Sengupta A.K., Kubicek S., Mechtler K., Spahn L., Koseki H., et al. Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing. EMBO J 2006, 25(13):3110-3122.
36. Tavares L., Dimitrova E., Oxley D., Webster J., Poot R., Demmers J., et al. RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3. Cell 2012, 148(4):664-678.
37. Cooper S., Dienstbier M., Hassan R., Schermelleh L., Sharif J., Blackledge N.P., et al. Targeting polycomb to pericentric heterochromatin in embryonic stem cells reveals a role for H2AK119u1 in PRC2 recruitment. Cell Rep 2014, 7(5):1456-1470.
38. Blackledge N.P., Farcas A.M., Kondo T., King H.W., McGouran J.F., Hanssen L.L., et al. Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation. Cell 2014, 157(6):1445-1459.
39. Kalb R., Latwiel S., Baymaz H.I., Jansen P.W., Muller C.W., Vermeulen M., et al. Histone H2A monoubiquitination promotes histone H3 methylation in Polycomb repression. Nat Struct Mol Biol 2014.
40. Francis N.J., Kingston R.E., Woodcock C.L. Chromatin compaction by a polycomb group protein complex. Science 2004, 306(5701):1574-1577.
41. Sexton T., Yaffe E., Kenigsberg E., Bantignies F., Leblanc B., Hoichman M., et al. Three-dimensional folding and functional organization principles of the Drosophila genome. Cell 2012, 148(3):458-472.
42. Eskeland R., Leeb M., Grimes G.R., Kress C., Boyle S., Sproul D., et al. Ring1B compacts chromatin structure and represses gene expression independent of histone ubiquitination. Mol Cell 2010, 38(3):452-464.
43. Trojer P., Cao A.R., Gao Z., Li Y., Zhang J., Xu X., et al. L3MBTL2 protein acts in concert with PcG protein-mediated monoubiquitination of H2A to establish a repressive chromatin structure. Mol Cell 2011, 42(4):438-450.
44. Chopra V.S., Hendrix D.A., Core L.J., Tsui C., Lis J.T., Levine M. The polycomb group mutant esc leads to augmented levels of paused Pol II in the Drosophila embryo. Mol Cell 2011, 42(6):837-844.
45. Stock J.K., Giadrossi S., Casanova M., Brookes E., Vidal M., Koseki H., et al. Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat Cell Biol 2007, 9(12):1428-1435.
46. Zhou W., Zhu P., Wang J., Pascual G., Ohgi K.A., Lozach J., et al. Histone H2A monoubiquitination represses transcription by inhibiting RNA polymerase II transcriptional elongation. Mol Cell 2008, 29(1):69-80.
47. Pasini D., Malatesta M., Jung H.R., Walfridsson J., Willer A., Olsson L., et al. Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res 2010, 38(15):4958-4969.
48. Pengelly A.R., Copur O., Jackle H., Herzig A., Muller J. A histone mutant reproduces the phenotype caused by loss of histone-modifying factor Polycomb. Science 2013, 339(6120):698-699.
49. Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006, 439(7078):871-874.
50. Pasini D., Hansen K.H., Christensen J., Agger K., Cloos P.A., Helin K. Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2. Genes Dev 2008, 22(10):1345-1355.
51. He A., Shen X., Ma Q., Cao J., von Gise A., Zhou P., et al. PRC2 directly methylates GATA4 and represses its transcriptional activity. Genes Dev 2012, 26(1):37-42.
52. Pasini D., Bracken A.P., Hansen J.B., Capillo M., Helin K. The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol Cell Biol 2007, 27(10):3769-3779.
53. Chamberlain S.J., Yee D., Magnuson T. Polycomb repressive complex 2 is dispensable for maintenance of embryonic stem cell pluripotency. Stem Cells 2008, 26(6):1496-1505.
54. Endoh M., Endo T.A., Endoh T., Fujimura Y., Ohara O., Toyoda T., et al. Polycomb group proteins Ring1A/B are functionally linked to the core transcriptional regulatory circuitry to maintain ES cell identity. Development 2008, 135(8):1513-1524.
55. Popov N., Gil J. Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health. Epigenet Off J DNA Methylation Soc 2010, 5(8):685-690.
56. Brockdorff N. Chromosome silencing mechanisms in X-chromosome inactivation: unknown unknowns. Development 2011, 138(23):5057-5065.
57. Sauvageau M., Sauvageau G. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 2010, 7(3):299-313.
58. Crea F., Paolicchi E., Marquez V.E., Danesi R. Polycomb genes and cancer: time for clinical application?. Crit Rev Oncol/Hematol 2012, 83(2):184-193.
59. Yap D.B., Chu J., Berg T., Schapira M., Cheng S.W., Moradian A., et al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 2011, 117(8):2451-2459.
60. Muto T., Sashida G., Oshima M., Wendt G.R., Mochizuki-Kashio M., Nagata Y., et al. Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders. J Exp Med 2013, 210(12):2627-2639.
61. Simon C., Chagraoui J., Krosl J., Gendron P., Wilhelm B., Lemieux S., et al. A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. Genes Dev 2012, 26(7):651-656.
62. Lewis P.W., Muller M.M., Koletsky M.S., Cordero F., Lin S., Banaszynski L.A., et al. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 2013, 340(6134):857-861.
63. Jacobs J.J., Scheijen B., Voncken J.W., Kieboom K., Berns A., van Lohuizen M. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 1999, 13(20):2678-2690.
64. Xu K., Wu Z.J., Groner A.C., He H.H., Cai C., Lis R.T., et al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science 2012, 338(6113):1465-1469.
65. Shi B., Liang J., Yang X., Wang Y., Zhao Y., Wu H., et al. Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol Cell Biol 2007, 27(14):5105-5119.
66. Lee S.T., Li Z.M., Wu Z.L., Aau M., Guan P.Y., Karuturi R.K.M., et al. Context-specific regulation of NF-kappa B target gene expression by EZH2 in breast cancers. Mol Cell 2011, 43(5):798-810.
67. Gonzalez M.E., Moore H.M., Li X., Toy K.A., Huang W., Sabel M.S., et al. EZH2 expands breast stem cells through activation of NOTCH1 signaling. Proc Natl Acad Sci U S A 2014, 111(8):3098-3103.
68. Dou Y., Milne T.A., Ruthenburg A.J., Lee S., Lee J.W., Verdine G.L., et al. Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat Struct Mol Biol 2006, 13(8):713-719.
69. Southall S.M., Wong P.S., Odho Z., Roe S.M., Wilson J.R. Structural basis for the requirement of additional factors for MLL1 SET domain activity and recognition of epigenetic marks. Mol Cell 2009, 33(2):181-191.
70. Dou Y., Milne T.A., Tackett A.J., Smith E.R., Fukuda A., Wysocka J., et al. Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell 2005, 121(6):873-885.
71. Petruk S., Sedkov Y., Smith S., Tillib S., Kraevski V., Nakamura T., et al. Trithorax and dCBP acting in a complex to maintain expression of a homeotic gene. Science 2001, 294(5545):1331-1334.
72. Bantignies F., Goodman R.H., Smolik S.M. Functional interaction between the coactivator Drosophila CREB-binding protein and ASH1, a member of the trithorax group of chromatin modifiers. Mol Cell Biol 2000, 20(24):9317-9330.
73. Hargreaves D.C., Crabtree G.R. ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res 2011, 21(3):396-420.
74. Wysocka J., Swigut T., Xiao H., Milne T.A., Kwon S.Y., Landry J., et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 2006, 442(7098):86-90.
75. Schmitges F.W., Prusty A.B., Faty M., Stutzer A., Lingaraju G.M., Aiwazian J., et al. Histone methylation by PRC2 is inhibited by active chromatin marks. Mol Cell 2011, 42(3):330-341.
76. Yuan W., Xu M., Huang C., Liu N., Chen S., Zhu B. H3K36 methylation antagonizes PRC2-mediated H3K27 methylation. J Biol Chem 2011, 286(10):7983-7989.
77. Lee M.G., Villa R., Trojer P., Norman J., Yan K.P., Reinberg D., et al. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 2007, 318(5849):447-450.
78. De Santa F., Totaro M.G., Prosperini E., Notarbartolo S., Testa G., Natoli G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 2007, 130(6):1083-1094.
79. Ruthenburg A.J., Allis C.D., Wysocka J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 2007, 25(1):15-30.
80. Sims R.J., Chen C.F., Santos-Rosa H., Kouzarides T., Patel S.S., Reinberg D. Human but not yeast CHD1 binds directly and selectively to histone H3 methylated at lysine 4 via its tandem chromodomains. J Biol Chem 2005, 280(51):41789-41792.
81. Ruthenburg A.J., Li H., Milne T.A., Dewell S., McGinty R.K., Yuen M., et al. Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions. Cell 2011, 145(5):692-706.
82. Shi X., Hong T., Walter K.L., Ewalt M., Michishita E., Hung T., et al. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 2006, 442(7098):96-99.
83. Vermeulen M., Mulder K.W., Denissov S., Pijnappel W.W., van Schaik F.M., Varier R.A., et al. Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 2007, 131(1):58-69.
84. Sims R.J., Millhouse S., Chen C.F., Lewis B.A., Erdjument-Bromage H., Tempst P., et al. Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol Cell 2007, 28(4):665-676.
85. Petruk S., Sedkov Y., Riley K.M., Hodgson J., Schweisguth F., Hirose S., et al. Transcription of bxd noncoding RNAs promoted by trithorax represses Ubx in cis by transcriptional interference. Cell 2006, 127(6):1209-1221.
86. Gu B., Lee M.G. Histone H3 lysine 4 methyltransferases and demethylases in self-renewal and differentiation of stem cells. Cell Biosci 2013, 3(1):39.
87. Wan M., Liang J., Xiong Y., Shi F., Zhang Y., Lu W., et al. The trithorax group protein Ash2l is essential for pluripotency and maintaining open chromatin in embryonic stem cells. J Biol Chem 2013, 288(7):5039-5048.
88. Ang Y.S., Tsai S.Y., Lee D.F., Monk J., Su J., Ratnakumar K., et al. Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 2011, 145(2):183-197.
89. Ho L., Jothi R., Ronan J.L., Cui K., Zhao K., Crabtree G.R. An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc Natl Acad Sci U S A 2009, 106(13):5187-5191.
90. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125(2):315-326.
91. Hu D., Garruss A.S., Gao X., Morgan M.A., Cook M., Smith E.R., et al. The Mll2 branch of the COMPASS family regulates bivalent promoters in mouse embryonic stem cells. Nat Struct Mol Biol 2013, 20(9):1093-1097.
92. Denissov S., Hofemeister H., Marks H., Kranz A., Ciotta G., Singh S., et al. Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant. Development 2014, 141(3):526-537.
93. Jiang H., Shukla A., Wang X., Chen W.Y., Bernstein B.E., Roeder R.G. Role for Dpy-30 in ES cell-fate specification by regulation of H3K4 methylation within bivalent domains. Cell 2011, 144(4):513-525.
94. Rampalli S., Li L., Mak E., Ge K., Brand M., Tapscott S.J., et al. p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nat Struct Mol Biol 2007, 14(12):1150-1156.
95. McKinnell I.W., Ishibashi J., Le Grand F., Punch V.G., Addicks G.C., Greenblatt J.F., et al. Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex. Nat Cell Biol 2008, 10(1):77-84.
96. Gori F., Friedman L.G., Demay M.B. Wdr5, a WD-40 protein, regulates osteoblast differentiation during embryonic bone development. Dev Biol 2006, 295(2):498-506.
97. Wu M.Z., Tsai Y.P., Yang M.H., Huang C.H., Chang S.Y., Chang C.C., et al. Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition. Mol Cell 2011, 43(5):811-822.
98. Cheng J., Blum R., Bowman C., Hu D., Shilatifard A., Shen S., et al. A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers. Mol Cell 2014, 53(6):979-992.
99. Herz H.M., Mohan M., Garruss A.S., Liang K., Takahashi Y.H., Mickey K., et al. Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3/Mll4. Genes Dev 2012, 26(23):2604-2620.
100. Hu D., Gao X., Morgan M.A., Herz H.M., Smith E.R., Shilatifard A. The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers. Mol Cell Biol 2013, 33(23):4745-4754.
101. Yip B.H., So C.W. Mixed lineage leukemia protein in normal and leukemic stem cells. Exp Biol Med 2013, 238(3):315-323.
102. Bernt K.M., Zhu N., Sinha A.U., Vempati S., Faber J., Krivtsov A.V., et al. MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell 2011, 20(1):66-78.
103. Cheung N., Chan L.C., Thompson A., Cleary M.L., So C.W. Protein arginine-methyltransferase-dependent oncogenesis. Nat Cell Biol 2007, 9(10):1208-1215.
104. Chen C., Liu Y., Rappaport A.R., Kitzing T., Schultz N., Zhao Z., et al. MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. Cancer Cell 2014, 25(5):652-665.
105. Kia S.K., Gorski M.M., Giannakopoulos S., Verrijzer C.P. SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus. Mol Cell Biol 2008, 28(10):3457-3464.
106. Roberts C.W., Leroux M.M., Fleming M.D., Orkin S.H. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell 2002, 2(5):415-425.
107. Schuettengruber B., Cavalli G. Recruitment of polycomb group complexes and their role in the dynamic regulation of cell fate choice. Development 2009, 136(21):3531-3542.
108. Sing A., Pannell D., Karaiskakis A., Sturgeon K., Djabali M., Ellis J., et al. A vertebrate Polycomb response element governs segmentation of the posterior hindbrain. Cell 2009, 138(5):885-897.
109. Woo C.J., Kharchenko P.V., Daheron L., Park P.J., Kingston R.E. A region of the human HOXD cluster that confers polycomb-group responsiveness. Cell 2010, 140(1):99-110.
110. Mendenhall E.M., Koche R.P., Truong T., Zhou V.W., Issac B., Chi A.S., et al. GC-rich sequence elements recruit PRC2 in mammalian ES cells. PLoS Genet 2010, 6(12):e1001244.
111. Milne T.A., Kim J., Wang G.G., Stadler S.C., Basrur V., Whitcomb S.J., et al. Multiple interactions recruit MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesis. Mol Cell 2010, 38(6):853-863.
112. Bina M., Wyss P., Novorolsky E., Zulkelfi N., Xue J., Price R., et al. Discovery of MLL1 binding units, their localization to CpG Islands, and their potential function in mitotic chromatin. BMC Genomics 2013, 14:927.
113. Li G., Margueron R., Ku M., Chambon P., Bernstein B.E., Reinberg D. Jarid2 and PRC2, partners in regulating gene expression. Genes Dev 2010, 24(4):368-380.
114. Kim H., Kang K., Kim J. AEBP2 as a potential targeting protein for Polycomb Repression Complex PRC2. Nucleic Acids Res 2009, 37(9):2940-2950.
115. Abed J.A., Jones R.S. H3K36me3 key to Polycomb-mediated gene silencing in lineage specification. Nat Struct Mol Biol 2012, 19(12):1214-1215.
116. Yu M., Mazor T., Huang H., Huang H.T., Kathrein K.L., Woo A.J., et al. Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors. Mol Cell 2012, 45(3):330-343.
117. Arnold P., Scholer A., Pachkov M., Balwierz P.J., Jorgensen H., Stadler M.B., et al. Modeling of epigenome dynamics identifies transcription factors that mediate Polycomb targeting. Genome Res 2013, 23(1):60-73.
118. Dietrich N., Lerdrup M., Landt E., Agrawal-Singh S., Bak M., Tommerup N., et al. REST-mediated recruitment of polycomb repressor complexes in mammalian cells. PLoS Genet 2012, 8(3):e1002494.
119. Villa R., Pasini D., Gutierrez A., Morey L., Occhionorelli M., Vire E., et al. Role of the polycomb repressive complex 2 in acute promyelocytic leukemia. Cancer Cell 2007, 11(6):513-525.
120. Boukarabila H., Saurin A.J., Batsche E., Mossadegh N., van Lohuizen M., Otte A.P., et al. The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation. Genes Dev 2009, 23(10):1195-1206.
121. Wang X., Zhu K., Li S., Liao Y., Du R., Zhang X., et al. MLL1, a H3K4 methyltransferase, regulates the TNFalpha-stimulated activation of genes downstream of NF-kappaB. J Cell Sci 2012, 125(Pt 17):4058-4066.
122. Brockdorff N. Noncoding RNA and Polycomb recruitment. RNA 2013, 19(4):429-442.
123. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129(7):1311-1323.
124. Wang K.C., Yang Y.W., Liu B., Sanyal A., Corces-Zimmerman R., Chen Y., et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 2011, 472(7341):120-124.
125. Bertani S., Sauer S., Bolotin E., Sauer F. The noncoding RNA Mistral activates Hoxa6 and Hoxa7 expression and stem cell differentiation by recruiting MLL1 to chromatin. Mol Cell 2011, 43(6):1040-1046.
126. Binda O. On your histone mark, SET, methylate!. Epigenet Off J DNA Methylation Soc 2013, 8(5):457-463.
127. Milne T.A., Briggs S.D., Brock H.W., Martin M.E., Gibbs D., Allis C.D., et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell 2002, 10(5):1107-1117.
128. Nightingale K.P., Gendreizig S., White D.A., Bradbury C., Hollfelder F., Turner B.M. Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation. J Biol Chem 2007, 282(7):4408-4416.
129. Guccione E., Bassi C., Casadio F., Martinato F., Cesaroni M., Schuchlautz H., et al. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 2007, 449(7164):933-937.
130. Kirmizis A., Santos-Rosa H., Penkett C.J., Singer M.A., Vermeulen M., Mann M., et al. Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation. Nature 2007, 449(7164):928-932.
131. Migliori V., Muller J., Phalke S., Low D., Bezzi M., Mok W.C., et al. Symmetric dimethylation of H3R2 is a newly identified histone mark that supports euchromatin maintenance. Nat Struct Mol Biol 2012, 19(2):136-144.
132. Yuan C.C., Matthews A.G., Jin Y., Chen C.F., Chapman B.A., Ohsumi T.K., et al. Histone H3R2 symmetric dimethylation and histone H3K4 trimethylation are tightly correlated in eukaryotic genomes. Cell Rep 2012, 1(2):83-90.
133. Varier R.A., Outchkourov N.S., de Graaf P., van Schaik F.M., Ensing H.J., Wang F., et al. A phospho/methyl switch at histone H3 regulates TFIID association with mitotic chromosomes. EMBO J 2010, 29(23):3967-3978.
134. Gehani S.S., Agrawal-Singh S., Dietrich N., Christophersen N.S., Helin K., Hansen K. Polycomb group protein displacement and gene activation through MSK-dependent H3K27me3S28 phosphorylation. Mol Cell 2010, 39(6):886-900.
135. Lau P.N., Cheung P. Histone code pathway involving H3 S28 phosphorylation and K27 acetylation activates transcription and antagonizes polycomb silencing. Proc Natl Acad Sci U S A 2011, 108(7):2801-2806.
136. Kim J.Y., Banerjee T., Vinckevicius A., Luo Q., Parker J.B., Baker M.R., et al. A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer. Mol Cell 2014.
137. Lau P.N., Cheung P. Histone phosphorylation: chromatin modifications that link cell signaling pathways to nuclear function regulation. Handbook of cell signaling 2009, 2399-2408. Academic Press, Oxford. 2nd ed. R.A. Bradshaw, E.A. Dennis (Eds.).
138. Cha T.L., Zhou B.P., Xia W., Wu Y., Yang C.C., Chen C.T., et al. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science 2005, 310(5746):306-310.
139. Nacerddine K., Beaudry J.B., Ginjala V., Westerman B., Mattiroli F., Song J.Y., et al. Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer. J Clin Invest 2012, 122(5):1920-1932.
140. Elderkin S., Maertens G.N., Endoh M., Mallery D.L., Morrice N., Koseki H., et al. A phosphorylated form of Mel-18 targets the Ring1B histone H2A ubiquitin ligase to chromatin. Mol Cell 2007, 28(1):107-120.
141. Palacios D., Mozzetta C., Consalvi S., Caretti G., Saccone V., Proserpio V., et al. TNF/p38alpha/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 2010, 7(4):455-469.
142. Forcales S.V., Albini S., Giordani L., Malecova B., Cignolo L., Chernov A., et al. Signal-dependent incorporation of MyoD-BAF60c into Brg1-based SWI/SNF chromatin-remodelling complex. EMBO J 2012, 31(2):301-316.
143. Drobic B., Perez-Cadahia B., Yu J., Kung S.K., Davie J.R. Promoter chromatin remodeling of immediate-early genes is mediated through H3 phosphorylation at either serine 28 or 10 by the MSK1 multi-protein complex. Nucleic Acids Res 2010, 38(10):3196-3208.
144. Chen S., Bohrer L.R., Rai A.N., Pan Y., Gan L., Zhou X., et al. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat Cell Biol 2010, 12(11):1108-1114.
145. Kaneko S., Li G., Son J., Xu C.F., Margueron R., Neubert T.A., et al. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev 2010, 24(23):2615-2620.
146. Wei Y., Chen Y.H., Li L.Y., Lang J., Yeh S.P., Shi B., et al. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat Cell Biol 2011, 13(1):87-94.
147. Nayak A., Viale-Bouroncle S., Morsczeck C., Muller S. The SUMO-specific isopeptidase SENP3 regulates MLL1/MLL2 methyltransferase complexes and controls osteogenic differentiation. Mol Cell 2014.
148. Steffen P.A., Ringrose L. What are memories made of? How Polycomb and Trithorax proteins mediate epigenetic memory. Nat Rev Mol Cell Biol 2014, 15(5):340-356.
149. Smith L.L., Yeung J., Zeisig B.B., Popov N., Huijbers I., Barnes J., et al. Functional crosstalk between Bmi1 and MLL/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells. Cell Stem Cell 2011, 8(6):649-662.
150. Shi J., Wang E., Zuber J., Rappaport A., Taylor M., Johns C., et al. The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia. Oncogene 2013, 32(7):930-938.
151. Tan J., Jones M., Koseki H., Nakayama M., Muntean A.G., Maillard I., et al. CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. Cancer Cell 2011, 20(5):563-575.
152. Campbell R.M., Tummino P.J. Cancer epigenetics drug discovery and development: the challenge of hitting the mark. J Clin Invest 2014, 124(1):64-69.
153. Dawson M.A., Kouzarides T., Huntly B.J. Targeting epigenetic readers in cancer. N Engl J Med 2012, 367(7):647-657.